Scientific Publishing and the Tobacco Industry

In January 2020 the US Food and Drug Administration (FDA) released a Guidance for the Industry about marketing flavors for e-cigarettes (https://am.ajph.link/fda_ guidance). The guidance was a retreat from previous commitments to ban all flavors except those that tasted like tobacco. Mitch Zeller, t...

Full description

Saved in:
Bibliographic Details
Published in:American journal of public health (1971) 2022-07, Vol.112 (7), p.951-951
Main Author: Morabia, Alfredo
Format: Article
Language:English
Subjects:
Cigarette industry
Cigarettes
Conflicts of interest
Editor's Choice
Electronic cigarettes
Ethics
Expectations
Federal regulation
Flavors
Food
Humans
Marketing
Minors
Nicotiana
Public health
Publishing
Scholarly publishing
Smoking
Tobacco
Tobacco Control
Tobacco Industry
Tobacco Smoke Pollution
Writing/Reviewing/Publishing
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In January 2020 the US Food and Drug Administration (FDA) released a Guidance for the Industry about marketing flavors for e-cigarettes (https://am.ajph.link/fda_ guidance). The guidance was a retreat from previous commitments to ban all flavors except those that tasted like tobacco. Mitch Zeller, then director of the FDA Center for Tobacco Products, explained it as a middle ground that would limit the extent of underage tobacco use without jeopardizing the potential of e-cigarettes to substitute tobacco in adult high-risk smokers (https:// am.ajph.link/FDA_ECIG).The journal invited scholars to give their opinion about the expected impact of the guidance on these two outcomes. All the contributions we received in 2020 were critical of the guidance, but they also gave the impression that the FDA had acted to conform to the industry's expectations. What were the industry's expectations specifically? We checked by asking Derek Yach, who was then the director of an organization funded by Philip Morris International, and Brad Radu, who declares receiving unrestricted grants from tobacco manufacturers, to comment. Their conflicts of interest were mentioned in their two comments and at the beginning of the themed section. Their comments were both critical of the guidance too, which was an important additional piece of information for our dossier.
ISSN:0090-0036
1541-0048
1541-0048
DOI:10.2105/AJPH.2022.306916